The default unit of preventive care is still the annual visit. One draw. One panel. One appointment on a calendar that was designed for billing cadence, not biology.
That design made sense when measurement was expensive and interpretation had to happen in a room with a person and a chart. It makes less sense now. Wearables stream heart rate, sleep, and recovery every night. Labs can be collected more than once a year without turning someone into a patient. The input side of the system has gone continuous. The decision side has not.
I build in this space, so I see the failure mode up close. A fasting glucose can sit inside the reference range for eighteen months while the personal baseline drifts. A lipid panel marked “normal” can hide a pattern that only shows up when you stack three draws against training load and sleep. Inflammation does not wait for an annual slot. Neither does the early biology of a disease that will eventually get a name.
The industry often frames this as a data problem. It is not. Data is already arriving. The problem is architecture.
Most health information still lands as disconnected artifacts. A PDF from a lab. An app with a proprietary score. An EHR note that another system cannot read. A clinician with twelve minutes and three screens. Nothing in that stack is built to treat a person as a time series. Everything is built to treat them as a case at a point in time.
If you were redesigning this as software, you would not start with a prettier PDF. You would start with a longitudinal record: sparse labs and dense wearable streams on one timeline, compared first to the person’s own baseline, then to population norms. You would decide sampling rate by rate of change, not by insurance habit. You would route only the exceptions that need judgment to a clinician, instead of routing every number through the same twelve-minute visit.
That is what I mean by continuous health intelligence. Not a gadget category. A system that assumes health unfolds over time, and is designed around that assumption.
This is also where AI is useful, and where it is not.
A model is good at holding more history in view than a person can keep in working memory. It can flag drift across sparse labs and dense streams. It can compress a noisy chart into the three changes that matter this week. It can draft the questions that make the next visit shorter. It can prioritize which signals need a clinician now and which can wait. Those are compression and routing jobs. They are the kind of work batch systems fail at when volume goes up.
A model is a bad substitute for the jobs that require relationship and irreversible judgment. Telling someone what a frightening result means in their life. Deciding to treat, wait, or dig when two clean options disagree. Catching the case where the data and the person do not match. Those do not compress cleanly. Peer-to-peer care still needs a peer.
The industry keeps collapsing those two layers. Chatbots that diagnose from a paragraph. Dashboards that shout “abnormal” without a baseline. Enterprise AI pitched as a doctor replacement because the demo sounds fluent. Fluency is not the constraint. The constraint is a care system that still batches decisions annually while the signals arrive daily.
I’m convicted by this because of personal loss. My father’s illness moved faster than the system’s attention. By the time the picture was clear, the window for earlier action had closed. That is what snapshot architecture does under time pressure. It is not a rare tragedy. It is the ordinary failure mode of a system that waits for something to be wrong enough to photograph.
If you are building here, the useful questions are operational.
What is the unit of decision? Annual visit, or change detection against a personal baseline?
Where does the longitudinal record live, and who can act on it?
Which jobs does the model take because they are high-volume and low-judgment, and which stay with a clinician because they are the opposite?
How do you stop a general-purpose tool from averaging your protocols toward someone else’s defaults?
Prevention that only wakes up once a year is delayed detection with better branding. The rebuild starts when we stop treating continuous data as an accessory to an annual ritual, and start treating the annual ritual as one sample inside a continuous system.
AI belongs in that rebuild as infrastructure for attention. Not as a second doctor. Not as a nicer chat window on top of the same batch process.
Nathan Graville’s dad was 58 when he died of cancer. He was healthy, active, doing everything right. The kind of person who always had energy and rarely got sick. But something was off, and no one caught it. Not because the tools didn’t exist, but because no one thought to look. He didn’t need a new workout plan. He needed a test no one ever ordered.
That silence became the reason Geviti exists.
Graville didn’t set out to build another wellness company. He wasn’t chasing a market trend or jumping into biohacking culture. He was trying to solve the problem that took his father’s life. And when you build something from that kind of loss, the result is different.
Most of the time, we wait until something hurts. That’s when the system kicks in. We schedule the visit. We get the test. But in many cases, that delay is the difference between manageable and permanent, between warning signs and life-altering diagnoses. Geviti flips the order. It’s not there for when you’re in crisis. It’s for when you feel fine and want to stay that way.
Here’s how it works. You start with Geviti’s Longeviti Panel, which checks over 100 biomarkers related to inflammation, hormone health, cardiovascular risk, metabolic performance, nutrient status, and more. It’s done at home. They send a mobile phlebotomist to your home to draw your blood. A few days later, your results arrive — with explanations and context, not just numbers.
Then you talk to a functional Wellness Specialist. Not a bot, not a generic assistant. An actual human with actual expertise and a reason to care. They walk you through your results and talk through next steps. You might get a plan for improving insulin sensitivity, adjusting sleep cycles, addressing hormone shifts, or managing silent inflammation. You don’t get told what to do. You get options, and support.
Everything runs through the app: results, recommendations, consults, supplement orders, questions. You can reach your care team by message or video. You can track changes, see what’s working, and adjust without the typical friction of healthcare.
Membership currently starts around $110 a month. That includes two Longeviti Panels a year, access to your medical provider, a dedicated wellness specialist, and a customized plan. Additional treatments, such as peptides or personalized supplements, are available at exclusive pricing. Geviti doesn’t just tell them what’s wrong. It tells them what to do about it. Then it helps them actually do it.
More about:
Nathan Graville is the Co-Founder & Chief Executive Officer of Geviti, bringing a strong entrepreneurial background to the healthcare services sector. Their experience demonstrates capabilities in strategic direction and operational oversight.
Nathan’s background is supported by a Bachelor of Business Administration from Grand Canyon University.
You can explore it for yourself at gogeviti.com.
